Skip to content

Author

Ross Arena

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Artificial intelligence for risk prediction in atherosclerotic cardiovascular disease: A narrative review of advances, validation challenges, and clinical translation (2020-2026).

Future work should prioritize calibration, robustness, transportability, fairness, interpretability, regulatory clarity, workflow integration, and prospective evidence of decision impact or post-deployment benefit, as well as major barriers remain.

Rui-Feng Liu, R. Arena, V. Vasile et al. · 0 citations
Review Aug 2026

The long-term prognostic value of triglyceride-glucose index in type 2 diabetics without clinical coronary artery disease.

In a cohort without known CAD, baseline TyG independently predicts long-term MACE in T2DM, and this simple, widely available metabolic marker may enhance cardiovascular risk stratification and MACE primary prevention strategies.

Yuval Avidan, D. Halon, Amir Yahav et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.